Earned income disappears the moment you stop working. Dividend income keeps arriving every quarter. That distinction drives serious investors toward portfolios built around cash-generative businesses with multi-decade payout histories, where the check arrives every quarter regardless of market conditions.
Starting fresh today, the temptation is to chase double-digit yields from leveraged BDCs and mortgage REITs. The smarter foundation is duller and more durable: Dividend Kings with consumer-staple cash flows that have outlasted recessions, inflation cycles, and management changes. Three names stand out, one from healthcare, one from beverages, and one from tobacco, with a combined dividend track record stretching back to the Eisenhower administration. Liquidity matters too. Unlike rental property or private credit, these positions can be sold in a single click if life intervenes.
We screened our 24/7 Wall St. dividend equity research database for stocks that pay massive dividends and found a collection that can generate over $2,500 a year in passive annual income if you invest $25,000 in each stock at the time of this writing.

Johnson & Johnson
- Yield: 2.39%
- Shares for $25,000: 111.5
- Annual Passive Income: $597.68
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) runs two segments after its consumer spinoff: Innovative Medicine, anchored by oncology blockbusters DARZALEX and immunology franchise TREMFYA, and MedTech, spanning cardiovascular devices, orthopaedics, surgery, and vision. Q1 2026 revenue rose 9.9% YoY to $24.06 billion, with adjusted EPS of $2.70 beating consensus.
Dividend reliability stems from scale and credit quality. JNJ historically carries a prime AAA credit rating, higher than that of the United States government, and just declared its 64th consecutive annual dividend increase, lifting the quarterly payout 3.1% to $1.34 per share. Institutional ownership sits at 76.2%, with Vanguard, BlackRock, and State Street collectively holding the largest stakes. Management is pursuing a planned orthopaedics separation to sharpen focus on six priority growth platforms.

Coca-Cola
- Yield: 2.71%
- Shares for $25,000: 319.7
- Annual Passive Income: $677.83
Coca-Cola (NYSE:KO) is the world’s largest non-alcoholic beverage company, with a portfolio spanning the namesake cola through Sprite, Fanta, Dasani, smartwater, Topo Chico, BODYARMOR, Powerade, Costa, Minute Maid, and fairlife. The asset-light, refranchised bottling model converts roughly every dollar of revenue into predictable concentrate cash flow, enabling management to guide to approximately $12.2 billion in free cash flow for 2026.
That cash flow funds a 63rd consecutive year of dividend increases, with the quarterly payout stepping to $0.53. Q1 2026 delivered 12.1% revenue growth to $12.47 billion and operating margin expansion to 35%. Coca-Cola Zero Sugar volume grew 13%. Vanguard, BlackRock, and Berkshire Hathaway anchor the institutional shareholder base, with management holding roughly $5.2 billion remaining in buyback authorization.

Altria
- Yield: 5.78%
- Shares for $25,000: 340.6
- Annual Passive Income: $1,443.95
Altria Group (NYSE:MO) is the U.S. tobacco leader behind Marlboro, Black & Mild, Copenhagen, Skoal, and the on! nicotine pouch line. The yield runs structurally higher than JNJ or KO for two reasons: secular volume decline in cigarettes keeps the share price suppressed, and management deliberately routes nearly all excess cash to shareholders. Smokeable segment margins reached 65.1% in Q1 2026, generating enough cash to fund $1.8 billion in dividends and $280 million in share repurchases in a single quarter.
The current quarterly dividend of $1.06 reflects the 60th increase in 56 years. Q1 2026 revenue jumped 20.1% to $5.43 billion, lifted by 610 million sticks of contract manufactured export cigarettes, and adjusted EPS of $1.32 beat consensus. Management reaffirmed full-year 2026 adjusted EPS guidance of $5.56 to $5.72.
The Bottom Line
Combined, these three positions generate $2,719.46 in annual passive income on a $75,000 investment, a blended yield of 3.63%. Altria contributes $1,443.95, Coca-Cola adds $677.83, and Johnson & Johnson rounds out the portfolio with $597.68.
| Ticker | Annual Income | Share of Total |
|---|---|---|
| MO | $1,443.95 | 53.1% |
| KO | $677.83 | 24.9% |
| JNJ | $597.68 | 22.0% |
Reinvested through a DRIP, that $2,719 buys roughly 12 additional JNJ shares, 8 KO shares, or nearly 20 MO shares each year at current prices, and next year’s payout grows from a larger share count. Pair that mechanical compounding with three management teams that have collectively raised dividends for 187 years, and the portfolio quietly compounds cash flow long after a paycheck stops.